51 - 100 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00203-9Best OA location URL: https://www.nature.com/articles/s41531-021-00203-9.pdfCitation Count: 83
-
RESTRICTEDTitle: Autosomal dominant Parkinson's disease caused by SNCA duplicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S1End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007Best OA location URL: https://europepmc.org/articles/pmc4820832?pdf=renderCitation Count: 151
- Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease2018RESTRICTEDTitle: Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson DiseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: S15End Page: S18Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.021Best OA location URL: http://manuscript.elsevier.com/S1353802017302687/pdf/S1353802017302687.pdfCitation Count: 14
-
RESTRICTEDTitle: The virtual reality of Parkinson's disease freezing of gait: A systematic reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 61Issue #:Start Page: 26End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.013Best OA location URL: https://europepmc.org/articles/pmc6773254?pdf=renderCitation Count: 23
- Cyclin-G-associated kinase modifies -synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study2011RESTRICTEDTitle: Cyclin-G-associated kinase modifies -synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD StudyJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 20Issue #: 8Start Page: 1478End Page: 1487Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddr026Best OA location URL: https://europepmc.org/articles/pmc3063983?pdf=renderCitation Count: 61
- α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies2023RESTRICTEDTitle: α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy BodiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 15Start Page: 12134End Page: 12134Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241512134Best OA location URL: https://www.mdpi.com/1422-0067/24/15/12134/pdf?version=1690553569Citation Count: 4
-
RESTRICTEDTitle: Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 18Start Page: 6513End Page: 6513Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21186513Best OA location URL: https://www.mdpi.com/1422-0067/21/18/6513/pdf?version=1599382153Citation Count: 21
- Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease2022RESTRICTEDTitle: Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 3Start Page: 1089End Page: 1089Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23031089Best OA location URL: https://www.mdpi.com/1422-0067/23/3/1089/pdf?version=1642743477Citation Count: 5
-
RESTRICTEDTitle: The cell biology of Parkinson’s diseaseJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 220Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1083/jcb.202012095Best OA location URL: https://rupress.org/jcb/article-pdf/220/4/e202012095/1412029/jcb_202012095.pdfCitation Count: 80
-
RESTRICTEDTitle: BCL-2 family: integrating stress responses at the ER to control cell demiseJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 24Issue #: 9Start Page: 1478End Page: 1487Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/cdd.2017.82Best OA location URL: https://www.nature.com/articles/cdd201782.pdfCitation Count: 188
-
RESTRICTEDTitle: HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasisJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 4Start Page: 539End Page: 550Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/sj.cdd.4401769Best OA location URL: https://www.nature.com/articles/4401769.pdfCitation Count: 372
-
RESTRICTEDTitle: Lipid-lowering drugsJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 63Issue #: 10Start Page: 1165End Page: 1178Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-005-5406-7Best OA location URL: https://europepmc.org/articles/pmc1986656?pdf=renderCitation Count: 190
-
RESTRICTEDTitle: Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunitiesJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 28Issue #: 2Start Page: 570End Page: 590Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41418-020-00706-7Best OA location URL: https://www.nature.com/articles/s41418-020-00706-7.pdfCitation Count: 216
- Neuropsychological Functioning in Primary Dystonia: Updated and Expanded Multidomain Meta‐Analysis2022RESTRICTEDTitle: Neuropsychological Functioning in Primary Dystonia: Updated and Expanded Multidomain Meta‐AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1483End Page: 1494Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29022Citation Count: 8
- Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis2021RESTRICTEDTitle: Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262606Citation Count: 1
- A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies2021RESTRICTEDTitle: A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studiesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 1Start Page: 13End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pds.5372Citation Count: 3
- Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases2016RESTRICTEDTitle: Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative DiseasesJournal Name: Annual Review of Pharmacology and ToxicologyPublisher: Annual ReviewsVol: 56Issue #: 1Start Page: 489End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1146/annurev-pharmtox-010715-103548Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010715-103548Citation Count: 72
-
RESTRICTEDTitle: The Evolving Role of Diffusion Magnetic Resonance Imaging in Movement DisordersJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-013-0400-1Best OA location URL: https://europepmc.org/articles/pmc3824956?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Value of genetic models in understanding the cause and mechanisms of Parkinson’s diseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 4Start Page: 288End Page: 296Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-008-0045-7Best OA location URL: https://europepmc.org/articles/pmc4431569?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Molecular Imaging and Updated Diagnostic Criteria in Lewy Body DementiasJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-017-0789-zBest OA location URL: https://europepmc.org/articles/pmc5873980?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: Cholinergic Dysfunction in Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-013-0377-9Best OA location URL: https://europepmc.org/articles/pmc3991467?pdf=renderCitation Count: 200
-
RESTRICTEDTitle: Chemical methods for the proteome-wide identification of posttranslationally modified proteinsJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 24Issue #:Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2014.10.020Best OA location URL: https://europepmc.org/articles/pmc4308425?pdf=renderCitation Count: 59
-
RESTRICTEDTitle: Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinsons DiseaseJournal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 3Start Page: 238End Page: 249Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1570159x13666151030103027Best OA location URL: https://europepmc.org/articles/pmc4857622?pdf=renderCitation Count: 54
- A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK22020RESTRICTEDTitle: A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.00153Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.00153/pdfCitation Count: 25
- Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care2020RESTRICTEDTitle: Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological careJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 623End Page: 634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30064-8Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/221521/221521.pdfCitation Count: 119
-
RESTRICTEDTitle: Detection, risk factors, and functional consequences of cerebral microinfarctsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 730End Page: 740Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30196-5Best OA location URL: http://manuscript.elsevier.com/S1474442217301965/pdf/S1474442217301965.pdfCitation Count: 230
-
RESTRICTEDTitle: Coding and Noncoding Variation in LRRK2 and Parkinson's Disease RiskJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 95End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28787Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28787Citation Count: 18
-
RESTRICTEDTitle: Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?Journal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 12Start Page: 2802End Page: 2816Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cne.23577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23577Citation Count: 46
-
RESTRICTEDTitle: Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-019-1532-2Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-019-1532-2Citation Count: 77
- Outcome measurement in functional neurological disorder: a systematic review and recommendations2020RESTRICTEDTitle: Outcome measurement in functional neurological disorder: a systematic review and recommendationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 638End Page: 649Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2019-322180Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/6/638.full.pdfCitation Count: 82
-
RESTRICTEDTitle: Normal and pathological gait: what we learn from Parkinson's disease: Figure 1Journal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 83Issue #: 10Start Page: 979End Page: 985Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2012-302263Best OA location URL: https://europepmc.org/articles/pmc3852420?pdf=renderCitation Count: 125
- Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death2009RESTRICTEDTitle: Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and deathJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 278Issue #: 1-2Start Page: 5End Page: 15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2008.12.010Best OA location URL: https://europepmc.org/articles/pmc2660887?pdf=renderCitation Count: 206
-
RESTRICTEDTitle: Longitudinal risk factors for developing depressive symptoms in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 429Issue #:Start Page: 117615End Page: 117615Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jns.2021.117615Best OA location URL: http://manuscript.elsevier.com/S0022510X21003099/pdf/S0022510X21003099.pdfCitation Count: 5
- Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development2021RESTRICTEDTitle: Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy developmentJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 424Issue #:Start Page: 117417End Page: 117417Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.117417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111569Citation Count: 12
-
RESTRICTEDTitle: Recognition and diagnosis of sleep disorders in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 259Issue #: 10Start Page: 2031End Page: 2040Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-012-6505-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-012-6505-7.pdfCitation Count: 36
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review2013RESTRICTEDTitle: Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 260Issue #: 11Start Page: 2701End Page: 2714Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-012-6798-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-012-6798-6.pdfCitation Count: 124
- Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic review2017RESTRICTEDTitle: Freezing of gait and fall detection in Parkinson’s disease using wearable sensors: a systematic reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1642End Page: 1654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-017-8424-0Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00415-017-8424-0.pdfCitation Count: 141
-
RESTRICTEDTitle: The clinical heterogeneity of drug-induced myoclonus: an illustrated reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1559End Page: 1566Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-016-8357-zBest OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs00415-016-8357-z.pdfCitation Count: 31
-
RESTRICTEDTitle: Proteomics of Human Neurodegenerative DiseasesJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 67Issue #: 10Start Page: 923End Page: 932Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/nen.0b013e318187a832Best OA location URL: https://academic.oup.com/jnen/article-pdf/67/10/923/9557140/67-10-923.pdfCitation Count: 35
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature2012RESTRICTEDTitle: Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 71Issue #: 5Start Page: 362End Page: 381Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/nen.0b013e31825018f7Best OA location URL: https://academic.oup.com/jnen/article-pdf/71/5/362/9561566/71-5-362.pdfCitation Count: 1568
- A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation2023RESTRICTEDTitle: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 83Issue #: 5Start Page: 389End Page: 402Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40265-023-01838-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-023-01838-z.pdfCitation Count: 9
- Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies2022RESTRICTEDTitle: Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathiesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00357-0Best OA location URL: https://www.nature.com/articles/s41531-022-00357-0.pdfCitation Count: 48
-
RESTRICTEDTitle: Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteinsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00230-6Best OA location URL: https://www.nature.com/articles/s41531-021-00230-6.pdfCitation Count: 24
-
RESTRICTEDTitle: Redefining the hypotheses driving Parkinson’s diseases researchJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00307-wBest OA location URL: https://www.nature.com/articles/s41531-022-00307-w.pdfCitation Count: 11
-
RESTRICTEDTitle: Parkinson’s disease: proteinopathy or lipidopathy?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0103-7Best OA location URL: https://www.nature.com/articles/s41531-019-0103-7.pdfCitation Count: 149
- Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature2019RESTRICTEDTitle: Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literatureJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0091-7Best OA location URL: https://www.nature.com/articles/s41531-019-0091-7.pdfCitation Count: 23
- Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders2022RESTRICTEDTitle: Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disordersJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 229Issue #:Start Page: 107937End Page: 107937Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107937Citation Count: 34
-
RESTRICTEDTitle: Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapyJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 175Issue #:Start Page: 105980End Page: 105980Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2021.105980Best OA location URL: http://manuscript.elsevier.com/S1043661821005648/pdf/S1043661821005648.pdfCitation Count: 12
-
RESTRICTEDTitle: Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2719End Page: 2730Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28815Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28815Citation Count: 22
-
RESTRICTEDTitle: Parkinson's Disease Modification Through Abl Kinase Inhibition: An OpportunityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 6End Page: 15Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28858Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770606Citation Count: 24